Laboratory Testing in the Intensive Care Unit

Critical Care Clinics

Volumn 23, Issue 3, 2007, Pages 435-465

  Ezzie, Michael E ^a   Aberegg, Scott K ^a   O'Brien Jr , James M ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; D DIMER; HEMOGLOBIN; LIVER ENZYME;

ANEMIA; ARTERIAL GAS; BLOOD CELL COUNT; BLOOD CULTURE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; OXYGEN TRANSPORT; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOCYTE COUNT; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME;

CRITICAL CARE; DECISION MAKING; HOSPITAL COSTS; HUMANS; INTENSIVE CARE UNITS; LABORATORY TECHNIQUES AND PROCEDURES; MONITORING, PHYSIOLOGIC; PHLEBOTOMY; REFERENCE STANDARDS; UNNECESSARY PROCEDURES;

EID: 34548845859     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2007.07.005     Document Type: Review

References (121)

1. Smoller B.R., and Kruskall M.S. Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med 314 19 (1986) 1233-1235
2. Zimmerman J.E., Seneff M.G., Sun X., et al. Evaluating laboratory usage in the intensive care unit: patient and institutional characteristics that influence frequency of blood sampling. Crit Care Med 25 5 (1997) 737-748
3. Garland A., Shaman Z., Baron J., et al. Physician-attributable differences in intensive care unit costs: a single-center study. Am J Respir Crit Care Med 174 11 (2006) 1206-1210
4. Frassica J.J. Frequency of laboratory test utilization in the intensive care unit and its implications for large-scale data collection efforts. J Am Med Inform Assoc 12 2 (2005) 229-233
5. Seguin P., Bleichner J.P., Grolier J., et al. Effects of price information on test ordering in an intensive care unit. Intensive Care Med 28 3 (2002) 332-335
6. Chalfin D.B. Analysis of cost-effectiveness in intensive care: an overview of methods and review of applications to problems in critical care. Curr Opin Anaesthesiol 9 (1996) 129-133
7. Klepzig H., Winten G., Thierolf C., et al. [Treatment costs in a medical intensive care unit: a comparison of 1992 and 1997]. Dtsch Med Wochenschr 123 23 (1998) 719-725
8. Young D.S., Sachais B.S., and Jefferies L.C. Laboratory costs in the context of disease. Clin Chem 46 7 (2000) 967-975
9. Asimos A. The trauma panel: laboratory test utilization in the initial evaluation of trauma patients. Emerg Med Rep 18 (1997) 22-31
10. Halpern N.A., Pastores S.M., and Greenstein R.J. Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs. Crit Care Med 32 6 (2004) 1254-1259
11. National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES). Centers for Disease Control. 2007. 3-20-0007. Ref Type: Electronic Citation.
12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 25 (2002) 3143-3421
13. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 13 10 (1985) 818-829
14. Lemeshow S., Klar J., and Teres D. Outcome prediction for individual intensive care patients: useful, misused, or abused?. Intensive Care Med 21 9 (1995) 770-776
15. Knaus W.A., Wagner D.P., Draper E.A., et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100 6 (1991) 1619-1636
16. Barie P.S., and Hydo L.J. Learning to not know: results of a program for ancillary cost reduction in surgical critical care. J Trauma 41 4 (1996) 714-720
17. Wang T.J., Mort E.A., Nordberg P., et al. A utilization management intervention to reduce unnecessary testing in the coronary care unit. Arch Intern Med 162 16 (2002) 1885-1890
18. Roberts D.E., Bell D.D., Ostryzniuk T., et al. Eliminating needless testing in intensive care-an information-based team management approach. Crit Care Med 21 10 (1993) 1452-1458
19. Neilson E.G., Johnson K.B., Rosenbloom S.T., et al. The impact of peer management on test-ordering behavior. Ann Intern Med 141 3 (2004) 196-204
20. Pilon C.S., Leathley M., London R., et al. Practice guideline for arterial blood gas measurement in the intensive care unit decreases numbers and increases appropriateness of tests. Crit Care Med 25 8 (1997) 1308-1313
21. Dighe A.S., Rao A., Coakley A.B., et al. Analysis of laboratory critical value reporting at a large academic medical center. Am J Clin Pathol 125 5 (2006) 758-764
22. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 6 (1992) 864-874
23. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 3 (2004) 858-873
24. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 19 (2001) 1368-1377
25. Gross A.S. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol 46 2 (1998) 95-99
26. Plebani M., and Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem 43 8 Pt 1 (1997) 1348-1351
27. Koch S.M., Warters R.D., and Mehlhorn U. The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. J Crit Care 17 3 (2002) 203-205
28. Irwig L., Tosteson A.N., Gatsonis C., et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120 8 (1994) 667-676
29. Cebul R.D., and Beck J.R. Biochemical profiles. Applications in ambulatory screening and preadmission testing of adults. Ann Intern Med 106 3 (1987) 403-413
30. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 32 1 (2004) 39-52
31. Raghavan M., and Marik P.E. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 127 1 (2005) 295-307
32. von Ahsen N., Muller C., Serke S., et al. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 27 12 (1999) 2630-2639
33. Woodhouse S. Complications of critical care: lab testing and iatrogenic anemia. MLO Med Lab Obs 33 (2001) 28-31
34. Vincent J.L., Baron J.F., Reinhart K., et al. Anemia and blood transfusion in critically ill patients. JAMA 288 12 (2002) 1499-1507
35. Dale J.C., and Ruby S.G. Specimen collection volumes for laboratory tests. Arch Pathol Lab Med 127 2 (2003) 162-168
36. Smoller B.R., Kruskall M.S., and Horowitz G.L. Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol 91 6 (1989) 701-703
37. Silver M.J., Li Y.H., Gragg L.A., et al. Reduction of blood loss from diagnostic sampling in critically ill patients using a blood-conserving arterial line system. Chest 104 6 (1993) 1711-1715
38. O'Hare D., and Chilvers R.J. Arterial blood sampling practices in intensive care units in England and Wales. Anaesthesia 56 6 (2001) 568-571
39. Carson J.L., Duff A., Poses R.M., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 9034 (1996) 1055-1060
40. Russell J.A., and Phang P.T. The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am J Respir Crit Care Med 149 2 Pt 1 (1994) 533-537
41. Corwin H.L. Blood transfusion in the critically ill patient. Dis Mon 45 10 (1999) 409-426
42. Moore F.A., Moore E.E., and Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 132 6 (1997) 620-624
43. Vamvakas E.C., and Carven J.H. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 122 2 (1998) 145-151
44. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340 6 (1999) 409-417
45. Hebert P.C., Yetisir E., Martin C., et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med 29 2 (2001) 227-234
46. Wu W.C., Rathore S.S., Wang Y., et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 17 (2001) 1230-1236
47. Rao S.V., Jollis J.G., Harrington R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 13 (2004) 1555-1562
48. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 321 6 (1989) 406-412
49. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342 18 (2000) 1301-1308
50. Suistomaa M., Kari A., Ruokonen E., et al. Sampling rate causes bias in APACHE II and SAPS II scores. Intensive Care Med 26 12 (2000) 1773-1778
51. Hindmarsh J.T., and Lyon A.W. Strategies to promote rational clinical chemistry test utilization. Clin Biochem 29 4 (1996) 291-299
52. Williamson J.W., Alexander M., and Miller G.E. Continuing education and patient care research. Physician response to screening test results. JAMA 201 12 (1967) 938-942
53. van Walraven C., and Naylor C.D. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 280 6 (1998) 550-558
54. Bates D.W., Boyle D.L., Rittenberg E., et al. What proportion of common diagnostic tests appear redundant?. Am J Med 104 4 (1998) 361-368
55. Hall J.B., Schmidt G.A., and Wood L.D.H. Principles of critical care (1998), The McGraw-Hill Company, Inc., New York
56. Bickler P.E., Feiner J.R., and Severinghaus J.W. Effects of skin pigmentation on pulse oximeter accuracy at low saturation. Anesthesiology 102 4 (2005) 715-719
57. Hampson N.B. Pulse oximetry in severe carbon monoxide poisoning. Chest 114 4 (1998) 1036-1041
58. MacLeod D.B., Cortinez L.I., Keifer J.C., et al. The desaturation response time of finger pulse oximeters during mild hypothermia. Anaesthesia 60 1 (2005) 65-71
59. Stoneham M.D. Uses and limitations of pulse oximetry. Br J Hosp Med 54 1 (1995) 35-41
60. Mason R.J., Broaddus V.C., Murray J.F., et al. Murray and Nadel's textbook of respiratory medicine. 4th edition (2005), Saunders, Philadelphia: WB
61. Frumin M.J., Epstein R.M., and Cohen G. Apneic oxygenation in man. Anesthesiology 20 (1959) 789-798
62. Tulaimat A., and Mokhlesi B. Noninvasive ventilation for persistent weaning failure. Am J Respir Crit Care Med 169 9 (2004) 1073-1074
63. Pell L.J., Martin B.S., and Shirk M.B. Epoetin alfa protocol and multidisciplinary blood-conservation program for critically ill patients. Am J Health Syst Pharm 62 4 (2005) 400-405
64. Laposata M.E., Laposata M., Van Cott E.M., et al. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med 128 12 (2004) 1424-1427
65. Clemmer T.P., Spuhler V.J., Oniki T.A., et al. Results of a collaborative quality improvement program on outcomes and costs in a tertiary critical care unit. Crit Care Med 27 9 (1999) 1768-1774
66. van Walraven C., Goel V., and Chan B. Effect of population-based interventions on laboratory utilization: a time-series analysis. JAMA 280 23 (1998) 2028-2033
67. Merlani P., Garnerin P., Diby M., et al. Quality improvement report: linking guideline to regular feedback to increase appropriate requests for clinical tests: blood gas analysis in intensive care. BMJ 323 7313 (2001) 620-624
68. Mehari S.M., Havill J.H., and Montgomery C. A written guideline implementation can lead to reductions in laboratory testing in an intensive care unit. Anaesth Intensive Care 25 1 (1997) 33-37
69. Zimmerman J., Fromm R., Meyer D., et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 99 13 (1999) 1671-1677
70. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 3 (2002) 161-167
71. Roongsritong C., Warraich I., and Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 125 5 (2004) 1877-1884
72. Phua J., Lim T.K., and Lee K.H. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med 33 9 (2005) 2094-2103
73. Ammann P., Maggiorini M., Bertel O., et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 41 11 (2003) 2004-2009
74. Lim W., Qushmaq I., Cook D.J., et al. Elevated troponin and myocardial infarction in the intensive care unit: a prospective study. Crit Care 9 6 (2005) R636-R644
75. Lim W., Cook D.J., Griffith L.E., et al. Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes. Am J Crit Care 15 3 (2006) 280-288
76. Lim W., Qushmaq I., Devereaux P.J., et al. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med 166 22 (2006) 2446-2454
77. Charpentier J., Luyt C.E., Fulla Y., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32 3 (2004) 660-665
78. Schwam E. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal. Acad Emerg Med 11 6 (2004) 686-691
79. Forfia P.R., Watkins S.P., Rame J.E., et al. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 45 10 (2005) 1667-1671
80. Jefic D., Lee J.W., Jefic D., et al. Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 128 1 (2005) 288-295
81. Dokainish H., Zoghbi W.A., Lakkis N.M., et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109 20 (2004) 2432-2439
82. Witthaut R., Busch C., Fraunberger P., et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29 10 (2003) 1696-1702
83. Dokainish H., Zoghbi W.A., Lakkis N.M., et al. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 93 9 (2004) 1130-1135
84. Tung R.H., Garcia C., Morss A.M., et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 32 8 (2004) 1643-1647
85. Abroug F., Ouanes-Besbes L., Nciri N., et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 174 9 (2006) 990-996
86. Grasso S., Leone A., De Michele M., et al. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease. Crit Care Med 35 1 (2007) 96-105
87. Brueckmann M., Huhle G., Lang S., et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112 4 (2005) 527-534
88. Landesberg G., Vesselov Y., Einav S., et al. Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med 33 6 (2005) 1281-1287
89. Raimondi P., Bongard O., de Moerloose P., et al. D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res 69 1 (1993) 125-130
90. Dempfle C.E., Zips S., Ergul H., et al. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT Study Group. Thromb Haemost 85 4 (2001) 671-678
91. Ginsberg J.S., Brill-Edwards P.A., Demers C., et al. D-dimer in patients with clinically suspected pulmonary embolism. Chest 104 6 (1993) 1679-1684
92. Bounameaux H., Cirafici P., de Moerloose P., et al. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 337 8735 (1991) 196-200
93. Wells P.S., Anderson D.R., Bormanis J., et al. Application of a diagnostic clinical model for the management of hospitalized patients with suspected deep-vein thrombosis. Thromb Haemost 81 4 (1999) 493-497
94. Crowther M.A., Cook D.J., Griffith L.E., et al. Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med 31 1 (2005) 48-55
95. Kollef M.H., Zahid M., and Eisenberg P.R. Predictive value of a rapid semiquantitative D-dimer assay in critically ill patients with suspected venous thromboembolic disease. Crit Care Med 28 2 (2000) 414-420
96. Kollef M.H., Eisenberg P.R., and Shannon W. A rapid assay for the detection of circulating D-dimer is associated with clinical outcomes among critically ill patients. Crit Care Med 26 6 (1998) 1054-1060
97. Shorr A.F., Thomas S.J., Alkins S.A., et al. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest 121 4 (2002) 1262-1268
98. Marik P.E. Fever in the ICU. Chest 117 3 (2000) 855-869
99. Aronson M.D., and Bor D.H. Blood cultures. Ann Intern Med 106 2 (1987) 246-253
100. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 1 (2000) 146-155
101. Grace C.J., Lieberman J., Pierce K., et al. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 32 11 (2001) 1651-1655
102. Pazin G.J., Saul S., and Thompson M.E. Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med 142 2 (1982) 263-268
103. Tabriz M.S., Riederer K., Baran Jr. J., et al. Repeating blood cultures during hospital stay: practice pattern at a teaching hospital and a proposal for guidelines. Clin Microbiol Infect 10 7 (2004) 624-627
104. Bates D.W., Goldman L., and Lee T.H. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA 265 3 (1991) 365-369
105. O'Grady N.P., Barie P.S., Bartlett J., et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med 26 2 (1998) 392-408
106. Smith-Elekes S., and Weinstein M.P. Blood cultures. Infect Dis Clin North Am 7 2 (1993) 221-234
107. Levin P.D., Hersch M., Rudensky B., et al. Routine surveillance blood cultures: their place in the management of critically ill patients. J Infect 35 2 (1997) 125-128
108. Salem M., Chernow B., Burke R., et al. Bedside diagnostic blood testing. Its accuracy, rapidity, and utility in blood conservation. JAMA 266 3 (1991) 382-389
109. Woo J., and Henry J.B. The advance of technology as a prelude to the laboratory of the twenty-first century. Clin Lab Med 14 3 (1994) 459-471
110. Harvey M.A. Point of care laboratory testing in critical care. Am J Crit Care 8 2 (1999) 72-83
111. Dungan K., Chapman J., Braithwaite S.S., et al. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 30 2 (2007) 403-409
112. Callaham M., and Barton C. Prediction of outcome of cardiopulmonary resuscitation from end-tidal carbon dioxide concentration. Crit Care Med 18 4 (1990) 358-362
113. Uehling M. Under the skin: sorting through the hype and hope for noninvasive POC devices. CAP Today 14 7 (2000) 52-68
114. Rubaltelli F.F., Gourley G.R., Loskamp N., et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics 107 6 (2001) 1264-1271
115. Bissell M. Point of care testing at the millennium. Crit Care Nurs Q 24 1 (2001) 39-43
116. Weiss I.K., Fink S., Harrison R., et al. Clinical use of continuous arterial blood gas monitoring in the pediatric intensive care unit. Pediatrics 103 2 (1999) 440-445
117. Zollinger A., Spahn D.R., Singer T., et al. Accuracy and clinical performance of a continuous intra-arterial blood-gas monitoring system during thoracoscopic surgery. Br J Anaesth 79 1 (1997) 47-52
118. Haller M., Kilger E., Briegel J., et al. Continuous intra-arterial blood gas and pH monitoring in critically ill patients with severe respiratory failure: a prospective, criterion standard study. Crit Care Med 22 4 (1994) 580-587
119. Widness J.A., Kulhavy J.C., Johnson K.J., et al. Clinical performance of an in-line point-of-care monitor in neonates. Pediatrics 106 3 (2000) 497-504
120. Inomata S., Nishikawa T., and Taguchi M. Continuous monitoring of mixed venous oxygen saturation for detecting alterations in cardiac output after discontinuation of cardiopulmonary bypass. Br J Anaesth 72 1 (1994) 11-16
121. Roupie E.E. Continuous assessment of arterial blood gases. Crit Care 1 1 (1997) 11-14